Ideal Cardiovascular Health Behaviors and NAFLD Prevalence

As a very common disorder, nonalcoholic fatty liver disease (NAFLD) is considered a significant risk factor for cardiovascular disease and a threat to cardiometabolic health. A series of ideal cardiovascular behaviors can be implemented as a prevention strategy to mitigate potential disease development. According to Ebenezer Oni, MD, MPH, cardiologist of the division of cardiology […]

Higher Daytime and Nighttime Blood Pressure Leads to Increased CVD, Mortality Risk in African American Adults

The association between hypertension and increased cardiovascular disease risk and all-cause mortality rates has been long known, however, there have been few studies evaluating the impact of high daytime and nighttime blood pressure levels on health outcomes in African-American adults. As the demographic holds the second highest percentage of CVD-related mortality, investigating the risk factors […]

5 Can’t Miss Topics at the 14th Annual CMHC

Top 5 Cardiometabolic Health Topics You Can’t Miss at the 14th Annual CMHC Alarmingly, recent statistics indicate that over one-third of the population has at least one cardiometabolic risk factor, ranging from dyslipidemia and hypertension to diabetes and cardiovascular disease. In the time of a cardiometabolic public health crisis, it is more important than ever […]

5 Cardiometabolic Health Topics You Can’t Miss at CMHC West 2019

With dozens of recently released revised clinical guidelines, breakthrough trial data, and newly approved drugs on the market, it is increasingly important for clinicians leading the fight against cardiometabolic disease to review the latest topics and industry developments. Explore how the most respected leaders of the industry are advancing cardiometabolic health and combating the growing […]

Aggressively Lowering LDL-C Reduces Cardiovascular Risk

Cardiovascular disease (CVD) is the leading cause of death in the United States, affecting more than 92 million people, with 45 million more being at an increased risk for developing CVD within 10 years. Elevated low-density lipoprotein cholesterol (LDL-C) is one of the key risk factors for CVD and several studies have shown that lowering […]

Coronary Artery Calcium as a Predictor of ASCVD Risk

Louis J. Aronne, MD, FACP

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in the US, and prevention of ASCVD is a public health priority in order to minimize its impacts on morbidity and mortality. Global CVD risk assessment is an integrated approach to evaluate the total risk of developing CVD over a given period (usually 10 years) […]

The Harms from Cigarette Smoking

Fasiha Kanwal, MD, MSHS, AGAF, FAASLD

A large study from the BMJ indicates that smokers must quit cigarettes, rather than simply cut back on them, to significantly lower their risk of heart disease and stroke. Statistics demonstrated that those who smoked even one cigarette each day were still about 50% more likely to develop CVD, and 30% more likely to have […]

Simple & Preventive Changes to Combat CVD

Carlos Olimpo Mendivil Anaya, MD, PhD

Cardiovascular disease has the highest mortality rate in the United States, and billions of dollars are given to pharmaceutical industries each year in order to combat and reduce risks. Yet recent research on cardiovascular risk factors offers renewed hope and optimism regarding heart disease, demonstrating a number of simple life changes to implement in order to prevent […]

More Aggressive Management of Hypertension Reduces Rates of CVD, Lowers Mortality Risk

Initial results of SPRINT (Systolic Blood Pressure Intervention Trial), a landmark clinical trial sponsored by the NIH, have shown that more aggressive management of hypertension significantly reduces the rate of cardiovascular disease and lowers the risk of mortality in a group of adults 50 years of age and older with hypertension. The trial, which began […]

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.